Literature DB >> 25425249

Septic cavernous sinus thrombosis caused by tuberculosis infection.

Peng Xia1, Yang Jiao1.   

Abstract

We report a rare case of acute, septic cavernous sinus thrombosis (SCST) caused by tuberculosis infection. The diagnosis of SCST was suspected and rapidly confirmed based on high fever, dramatic and typical signs of left cranial nerve paralysis and the result of digital subtraction angiography after the onset of the disease. However, the diagnosis of tuberculosis infection was missed, and the 55-year-old patient was treated with high-dose glucocorticoid, anticoagulants and a series of intravenous antibiotics for bacteria. His symptoms failed to improve, and steroid treatment resulted in serious haematogenous dissemination of Mycobacterium tuberculosis, including miliary tuberculosis and tuberculosis verrucosa cutis, which led to the final diagnosis. Then, the patient received a five-agent antituberculosis treatment. He was recently followed up with only the sequelae of left side ptosis and oculomotor weakness. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25425249      PMCID: PMC4248139          DOI: 10.1136/bcr-2014-206209

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  Cavernous sinus thrombosis: current therapy.

Authors:  Valmont Desa; Ryan Green
Journal:  J Oral Maxillofac Surg       Date:  2012-02-09       Impact factor: 1.895

Review 2.  Tuberculous meningitis in adults: a review of a decade of developments focusing on prognostic factors for outcome.

Authors:  Flavia Brancusi; Jeremy Farrar; Dorothee Heemskerk
Journal:  Future Microbiol       Date:  2012-09       Impact factor: 3.165

Review 3.  Tuberculosis infections of the central nervous system.

Authors:  Ronald Bartzatt
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2011-12-01

4.  EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients.

Authors:  K Einhäupl; J Stam; M-G Bousser; S F T M De Bruijn; J M Ferro; I Martinelli; F Masuhr
Journal:  Eur J Neurol       Date:  2010-10       Impact factor: 6.089

5.  Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis.

Authors:  Jonathan M Coutinho; José M Ferro; Patrícia Canhão; Fernando Barinagarrementeria; Marie-Germaine Bousser; Jan Stam
Journal:  Stroke       Date:  2010-10-07       Impact factor: 7.914

6.  Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis.

Authors:  J W C Alffenaar; R van Altena; H J Bökkerink; G J Luijckx; D van Soolingen; R E Aarnoutse; T S van der Werf
Journal:  Clin Infect Dis       Date:  2009-10-01       Impact factor: 9.079

Review 7.  Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.

Authors:  Antonello Di Paolo; Giovanni Gori; Carlo Tascini; Romano Danesi; Mario Del Tacca
Journal:  Clin Pharmacokinet       Date:  2013-07       Impact factor: 6.447

Review 8.  Septic thrombosis of the cavernous sinuses.

Authors:  M J DiNubile
Journal:  Arch Neurol       Date:  1988-05

Review 9.  The role of anticoagulation in cavernous sinus thrombosis.

Authors:  S R Levine; R E Twyman; S Gilman
Journal:  Neurology       Date:  1988-04       Impact factor: 9.910

10.  The cavernous sinus syndrome. An anatomical and clinical study.

Authors:  J J van Overbeeke; J J Jansen; C A Tulleken
Journal:  Clin Neurol Neurosurg       Date:  1988       Impact factor: 1.876

View more
  1 in total

1.  Deep vein thrombosis of the left arm revealing an asymptomatic pulmonary tuberculosis.

Authors:  Anis Hariz; Mouna Guermazi; Mohamed Salah Hamdi; Imen Boukhris
Journal:  BMJ Case Rep       Date:  2019-06-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.